Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what steps he is taking to promote the use of (a) engineering controls, (b) biological safety cabinets and (c) closed‑system drug‑transfer devices during the (i) preparation and (ii) administration of hazardous medicinal products; and whether he plans to allocate funding to implement these controls to NHS Trusts.

Where hazardous medicinal products (HMPs) are substances hazardous to health subject to The Control of Substances Hazardous to Health Regulations 2002 (as amended) (COSHH) employers, including NHS Trusts, are required to comply with the requirements of these regulations.

The regulations require employers who prepare and administer substances hazardous to health to undertake a risk assessment, the purpose of which is to make valid decisions about the measures needed to prevent, or where this is not reasonably practicable, adequately control the exposure of their employees to substances hazardous to health.

If it is not reasonably practicable for an employer to prevent exposure, the regulations require that the exposure of employees is adequately controlled and through the risk assessment process that the employer considers and identifies the control measures that should be implemented. Priority should be given to those controls that contain or minimise the release of contaminants and the spread of hazardous substances into the workplace.

The Approved Code of Practice and guidance to the COSHH regulations provides employers with detailed information and guidance on the requirements of the regulations. The Health and Safety Executive (HSE) has also produced specific guidance on it’s website on the Safe handling of cytotoxic drugs in the workplace, which are one particular type of HMP.